Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Generos Biopharma Ltd. operates within the Biotechnology & Pharmaceuticals technology area and currently has 1 pending office action. This workload is being handled by 1 distinct examiner in 1 distinct art unit, indicating a highly focused prosecution environment. Such a concentrated portfolio means that the company's immediate patent goals are tied to a specific technical review process. This allows for a streamlined response strategy but also concentrates the risk of a negative outcome with 1 individual.
The busiest examiner for the portfolio is GONZALEZ, LUISALBERTO, who is responsible for the 1 busiest examiner pending office action. As the examiner currently assigned to the company's pending work, this individual's perspective is critical to the portfolio's progress. With the interaction limited to 1 distinct examiner and 1 distinct art unit, there is no internal variation in how the patent office is evaluating the company's biotechnology claims. Practitioners should focus on addressing the specific requirements of the 1 pending office action to move the application toward allowance.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GONZALEZ, LUISALBERTO | 1 | 59.4% | +47.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18033292 | FUSED RING-CONTAINING COMPOUND, APPLICATION THEREOF, AND COMPOSITION CONTAINING SAME | GONZALEZ, LUISALBERTO | 27d |
| Art Unit | Apps |
|---|---|
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18033292 | FUSED RING-CONTAINING COMPOUND, APPLICATION THEREOF, AND COMPOSITION CONTAINING SAME | GONZALEZ, LUISALBERTO | 1624 | §112 | Non-Final OA | 27d | Pending | Apr 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial